이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Epsilon Healthcare 과거 수익 실적

과거 기준 확인 0/6

Epsilon Healthcare의 수입은 연평균 -4.2%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 수입이 연평균 35.6%의 비율로 증가했습니다. 매출은 연평균 16.1%의 비율로 증가해 왔습니다.

주요 정보

-4.2%

수익 성장률

9.1%

EPS 성장률

Pharmaceuticals 산업 성장	31.2%
매출 성장률	16.1%
자기자본 수익률	-64.7%
순이익	-82.2%
최근 수익 업데이트	30 Jun 2023

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

Epsilon Healthcare 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

ASX:EPN 수익, 비용 및 수입 (AUD Millions )
날짜	수익	수익	G+A 비용
30 Jun 23	7	-6	5
31 Mar 23	7	-10	6
31 Dec 22	7	-13	6
30 Sep 22	6	-13	7
30 Jun 22	5	-13	7
31 Mar 22	5	-11	8
31 Dec 21	5	-9	10
30 Sep 21	6	-9	11
30 Jun 21	7	-9	12
31 Mar 21	7	-10	11
31 Dec 20	7	-11	11
30 Sep 20	7	-11	11
30 Jun 20	6	-12	11
31 Mar 20	5	-12	10
31 Dec 19	5	-12	10
30 Sep 19	4	-11	9
30 Jun 19	4	-11	9
31 Mar 19	3	-10	9
31 Dec 18	3	-9	8
30 Sep 18	3	-7	7
30 Jun 18	3	-5	6
31 Mar 18	2	-4	5
31 Dec 17	2	-3	3

양질의 수익: EPN 은(는) 현재 수익성이 없습니다.

이익 마진 증가: EPN 은(는) 현재 수익성이 없습니다.

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: EPN 은(는) 수익성이 없으며 지난 5년 동안 연간 4.2% 비율로 손실이 증가했습니다.

성장 가속화: 현재 수익성이 없기 때문에 EPN 의 지난 1년 동안의 수익 성장을 5년 평균과 비교할 수 없습니다.

수익 대 산업: EPN 은(는) 수익성이 없어 지난 해 수익 성장을 Pharmaceuticals 업계( 28.2% )와 비교하기 어렵습니다.

자기자본 수익률

높은 ROE: EPN 현재 수익성이 없기 때문에 마이너스 자본 수익률( -64.69% )을 갖습니다.

Epsilon Healthcare 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Recent updates

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

자기자본 수익률

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기